Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,283 | -86,620 | -98,426 | -108,882 | -101,320 |
| Depreciation Amortization | 1,406 | -1,493 | 800 | 2,026 | 3,406 |
| Accounts payable and accrued liabilities | 481 | -2,475 | 846 | 1,614 | 135 |
| Other Working Capital | -32,140 | -32,266 | -41,879 | 281,546 | 33,441 |
| Other Operating Activity | 18,437 | 22,448 | 20,553 | 17,308 | 14,088 |
| Operating Cash Flow | $-86,099 | $-100,406 | $-118,106 | $193,612 | $-50,250 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -131,247 | -261,470 | -73,901 | -409,345 | -99,984 |
| PPE Investments | -50 | -906 | -1,224 | -1,210 | -3,313 |
| Purchase Of Investment | 243,337 | 232,472 | 219,575 | 166,233 | 139,470 |
| Investing Cash Flow | $112,040 | $-29,904 | $144,450 | $-244,322 | $36,173 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 483 | 106,013 | 1,778 | 1,763 | 1,418 |
| Other Financing Activity | 540 | -585 | 0 | 0 | 21,000 |
| Financing Cash Flow | $1,023 | $105,428 | $1,778 | $1,763 | $22,418 |
| Beginning Cash Position | 57,162 | 82,044 | 53,922 | 102,869 | 94,528 |
| End Cash Position | 84,126 | 57,162 | 82,044 | 53,922 | 102,869 |
| Net Cash Flow | $26,964 | $-24,882 | $28,122 | $-48,947 | $8,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,099 | -100,406 | -118,106 | 193,612 | -50,250 |
| Capital Expenditure | -50 | -906 | -1,224 | -1,210 | -3,313 |
| Free Cash Flow | -86,149 | -101,312 | -119,330 | 192,402 | -53,563 |